Conditions: Rosacea
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 114
Healthy volunteers: no

Brief summary:
Phase 3 efficacy and safety study of CD07805/47 topical gel in subjects with facial erythema associated with rosacea. The study hypothesis is that CD07805/47 gel, applied topically once daily is more efficacious than vehicle and provides an acceptable safety profile in the treatment of facial erythema associated with rosacea

Detailed description:

Arms:
arm 1: Placebo arm 2: Intervention: Drug: CD07805/47 gel

Interventions: intervention 1: Drug: CD07805/47 gel intervention 2: CD07805/47 gel Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: